Smartstop Self Storage REIT (SMA) Stock Price, News & Analysis

Company Overview

Symmetry Medical Inc. (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). It also manufactures specialized non-healthcare products, primarily in the aerospace industry. The Company operates in two segments: original equipment manufacturer (OEM) solutions and symmetry surgical. On August 15, 2011, the Company acquired PSC Industries, Inc's Olsen Medical division. On December 29, 2011 it acquired the surgical instruments product portfolio from Codman & Shurtleff, Inc., a Johnson & Johnson Company.

Key Stats

• Today's Range: $33.73 to $34.66
• 50-Day Range: $13,350.00 to $16,000.00
• 52-Week Range: N/A
• Volume: 279,841 shs
• Average Volume: 557,728 shs
• Market Capitalization: $1.88 billion
• P/E Ratio: N/A
• Dividend Yield: 4.80%
• Price Target: $39.10
• Consensus Rating: Buy

SMA Stock Analysis - Frequently Asked Questions

How were Smartstop Self Storage REIT's earnings last quarter?

Smartstop Self Storage REIT Inc (NYSE:SMA) issued its quarterly earnings results on Wednesday, August, 6th. The healthcare company reported $0.42 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.43 by $0.01. The healthcare company earned $66.82 million during the quarter, compared to analyst estimates of $65.61 million. Smartstop Self Storage REIT had a negative trailing twelve-month return on equity of 2.09% and a negative net margin of 5.15%.
Read the conference call transcript.

When did Smartstop Self Storage REIT IPO?

Smartstop Self Storage REIT (SMA) raised $810 million in an initial public offering (IPO) on Wednesday, April 2nd 2025. The company issued 27,000,000 shares at $30.00 per share.

When does the company's lock-up period expire?

Smartstop Self Storage REIT's lock-up period expires on Monday, September 29th. Smartstop Self Storage REIT had issued 27,000,000 shares in its IPO on April 2nd. The total size of the offering was $810,000,000 based on an initial share price of $30.00. After the expiration of the company's lock-up period, company insiders and major shareholders will be able to sell their shares of the company.

Who are Smartstop Self Storage REIT's major shareholders?

Smartstop Self Storage REIT's top institutional shareholders include Geode Capital Management LLC (1.20%), Aberdeen Group plc (0.83%), Cbre Investment Management Listed Real Assets LLC (0.83%) and Allspring Global Investments Holdings LLC (0.66%). Insiders that own company stock include H Michael Schwartz, Michael O Terjung, Wayne Johnson and Nicholas Look.
View institutional ownership trends.

What other stocks do shareholders of Smartstop Self Storage REIT own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Smartstop Self Storage REIT investors own include Consort Medical plc (CSRT.L) (CSRT), Achillion Pharmaceuticals (ACHN), Boeing (BA), Cencora (COR), Alphabet (GOOG), Illumina (ILMN) and Newcrest Mining (NCM).

Company Calendar

• Record date for 8/15 Dividend: 7/31/2025
• Ex-Dividend for 8/15 Dividend: 7/31/2025
• Last Earnings: 8/06/2025
• Today: 8/10/2025
• Dividend Payable: 8/15/2025
• Record date for 9/3 Dividend: 8/29/2025
• Ex-Dividend for 9/3 Dividend: 8/29/2025
• Dividend Payable: 9/03/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Finance
• Industry: REIT - EQTY TRUST - OTHER
• Sub-Industry: Health Care Equipment
• Current Symbol: NYSE:SMA
• CIK: 1292055
• Web: www.smartstopselfstorage.com
• Phone: +1-574-2682252
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Smartstop Self Storage REIT: $39.10
• High Price Target: $44.00
• Low Price Target: $36.00
• Potential Upside/Downside: +15.1%
• Consensus Rating: Buy
• Rating Score (0-4): 3.25
• Research Coverage: 12 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$5.62 million
• Net Margins: -5.15%
• Pretax Margin: -4.77%
• Return on Equity: -2.09%
• Return on Assets: -0.63%

Debt

• Debt-to-Equity Ratio: 0.73
• Current Ratio: 5.35
• Quick Ratio: 3.23

Sales & Book Value

• Annual Sales: $237.01 million
• Price / Sales: 7.95
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 55,460,000
• Free Float: 52,407,000
• Market Cap: $1.88 billion
• Optionable: Not Optionable
• Beta: N/A